On October 2, 2024, MeCure Industries Plc, one of Nigeria’s leading pharmaceutical companies, announced the sale of a 10% equity stake to Zrosk Investment Management Ltd.
The post Analysis: The impact of Zrosk’s 10% stake on MeCure’s growth and investor confidence appeared first on Nairametrics.